INTRODUCTION: Increased lymph node (LN) retrieval for gastric cancer has been associated with improved overall survival (OS). This study examines the impact of number of examined LN (eLN) and lymph node ratio. METHODS: Patients referred for surgical care of gastric cancer were stratified by number of eLN, positive LNs (LN+), and lymph node ratio (LN+/eLN). Clinicopathologic factors were compared; OS and disease-free survival (DFS) were the primary endpoints. RESULTS: From 1997 to 2012, 222 patients, median age 67 (range, 17-92) years, were analyzed. Of 220 (99 %) explored, 164 (74 %) underwent resection. Median OS was 22 (range, 0.3-140) months. Perineural and lymphovascular invasion and poor differentiation adversely affected OS, p < 0.05. A median 14 eLN (range, 0-45), with median 1 LN+ (range, 0-31), was observed. There were no OS or DFS differences when comparing the eLN groups. Both OS and DFS were impacted by LN+. Lymph node ratio demonstrated worse median OS with increasing ratio: 49 months (0) to 37 months (0.01-0.2), 27 months (0.21-0.5), and 12 months (>0.5), p < 0.0001. DFS was similar: 35 months (0), decreasing to 22 months (0.01-0.2), 13 months (0.21-0.5), and 7 months (>0.5), p < 0.0001. CONCLUSION: Number of eLN did not impact survival, while LN+ adversely affected survival. Lymph node ratio may predict prognosis better than number of eLN or LN+ in gastric cancer.
INTRODUCTION: Increased lymph node (LN) retrieval for gastric cancer has been associated with improved overall survival (OS). This study examines the impact of number of examined LN (eLN) and lymph node ratio. METHODS:Patients referred for surgical care of gastric cancer were stratified by number of eLN, positive LNs (LN+), and lymph node ratio (LN+/eLN). Clinicopathologic factors were compared; OS and disease-free survival (DFS) were the primary endpoints. RESULTS: From 1997 to 2012, 222 patients, median age 67 (range, 17-92) years, were analyzed. Of 220 (99 %) explored, 164 (74 %) underwent resection. Median OS was 22 (range, 0.3-140) months. Perineural and lymphovascular invasion and poor differentiation adversely affected OS, p < 0.05. A median 14 eLN (range, 0-45), with median 1 LN+ (range, 0-31), was observed. There were no OS or DFS differences when comparing the eLN groups. Both OS and DFS were impacted by LN+. Lymph node ratio demonstrated worse median OS with increasing ratio: 49 months (0) to 37 months (0.01-0.2), 27 months (0.21-0.5), and 12 months (>0.5), p < 0.0001. DFS was similar: 35 months (0), decreasing to 22 months (0.01-0.2), 13 months (0.21-0.5), and 7 months (>0.5), p < 0.0001. CONCLUSION: Number of eLN did not impact survival, while LN+ adversely affected survival. Lymph node ratio may predict prognosis better than number of eLN or LN+ in gastric cancer.
Authors: Jingyu Deng; Han Liang; Dianchang Wang; Dan Sun; Xuewei Ding; Yi Pan; Xiangyu Liu Journal: Ann Surg Oncol Date: 2009-12-29 Impact factor: 5.344
Authors: W Wang; D Z Xu; Y F Li; Y X Guan; X W Sun; Y B Chen; R Kesari; C Y Huang; W Li; Y Q Zhan; Z W Zhou Journal: Ann Oncol Date: 2011-02-10 Impact factor: 32.976
Authors: Koen C M J Peeters; Michael W Kattan; Henk H Hartgrink; Elma Klein Kranenbarg; Martin S Karpeh; Murray F Brennan; Cornelis J H van de Velde Journal: Cancer Date: 2005-02-15 Impact factor: 6.860
Authors: Sung Hwan Hwang; Hyun Il Kim; Jun Seong Song; Min Hong Lee; Sung Joon Kwon; Min Gyu Kim Journal: J Gastric Cancer Date: 2016-12-20 Impact factor: 3.720
Authors: Stefano Rausei; Laura Ruspi; Federica Galli; Vincenzo Pappalardo; Giuseppe Di Rocco; Francesco Martignoni; Francesco Frattini; Francesca Rovera; Luigi Boni; Gianlorenzo Dionigi Journal: World J Gastroenterol Date: 2016-09-14 Impact factor: 5.742